Pathway-Guided and Patient-Centered Therapeutic Strategies in Atherosclerotic Cardiovascular Disease.
A novel pathway- and phenotype-based conceptual framework is proposed for individualized ASCVD management and secondary prevention that integrates residual-risk phenotypes with clinical characteristics, comorbidities, vascular territory, and treatment-related considerations to support residual-risk-guided selection of...